TransCode Therapeutics, Inc. Common Stock

RNAZ

...

RNAZ: TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat cancer through the intelligent design and effective delivery of RNA therapeutics. The company's therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian, and colon cancer, glioblastomas, and others.

Show RNAZ Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of RNAZ by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by RNAZ's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on RNAZ's company Twitter account

WallStreetBets

Number of mentions of RNAZ in WallStreetBets Daily Discussion

RNAZ News

Recent insights relating to RNAZ

CNBC Recommendations

Recent picks made for RNAZ stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RNAZ

Corporate Flights

Flights by private jets registered to RNAZ